The associate professor of neurology at McMaster University talked about findings from secondary analyses on the phase 4 ANNEXA-I trial assessing andexanet alfa in patients with acute intracerebral hemorrhage. [WATCH TIME: 10 minutes]
Ashkan Shoamanesh, MD
Advertisement
Associate professor of neurology at McMaster University.
Articles by Ashkan Shoamanesh, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
2
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
3
Apomorphine Sublingual Film Displays Efficacy in Elderly Patients with Parkinson Disease
4
Expanding Patient Expectations When Managing Generalized Myasthenia Gravis: A Treating Physician’s Experience with IMAAVY™ (nipocalimab-aahu)
5
